瑞舒伐他汀对冠状动脉支架术后患者的干预研究  被引量:3

Intervention with Rosuvastatin for Patients after Coronary Stenting

在线阅读下载全文

作  者:杨宇[1] 冯德辉[1] 王俊贤[1] 黄石安[1] 

机构地区:[1]广东医学院附属医院,广东湛江524001

出  处:《河北医学》2013年第9期1290-1293,共4页Hebei Medicine

摘  要:目的:探讨瑞舒伐他汀对冠脉支架术后患者的影响。方法:选择我院2010年2月至2012年3月收治的急性冠脉综合征行冠脉支架植入术患者114例,随机分为观察组(n=57)和对照组(n=57);观察组患者术后给予常规用药加用瑞舒伐他汀,对照组患者术后给予常规用药,两组均治疗6个月。治疗结束后复行冠脉造影,观察比较两组患者的冠脉支架再狭窄率、心绞痛再发率及血脂和C反应蛋白(CRP)水平变化及不良反应。结果:观察组冠脉支架再狭窄率、心绞痛再发率明显低于对照组,差异有统计学意义(P<0.05);两组用药后血脂和CRP水平均比用药前明显改善,用药后观察组TC、TG、LDL-C、CRP水平明显低于对照组,HDL-C水平明显高于对照组,差异均有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:瑞舒伐他汀可显著改善冠脉支架术后再狭窄、心绞痛再发,有效调节血脂和抑制炎症,值得临床进一步推广。To investigate the effect of rosuvastatin for patients with coronary stenting.Method: 114 patients with acute coronary syndrome admitted to our hosoital from Feb. 2010 to Mar. 2012 were randomly divided into observation group ( n = 571 and control group ( n = 577. The observation group was treated with rosuvastatin based on conventional medication and the control group was treated with conventional medication. After 6 months of treatment, all patients were observed by coronary arteriography. Restenosis rate of coronary stent, recurrence rate of angina, levels of blood lipids and C-reactive protein (CRP) , and adverse reactions were observed and compared between the two groups. Result: The restenosis rate of coronary stent, recurrence rate of angina of the observation group were significantly lower than those of the control group ( P〈0.05 ). The levels of lipids and CRP were improved of all patients. The levels of TC, TG, LDL-C and CRP of the observation group were significantly lower than those of the control group, and the level of HDL-C was significantly higher than that of the control group ( P〈0.05). There was no significant difference of the incidence of adverse reactions between the two groups ( P〉0.05 }. Conehtsion: Rosuvastatin is effective to improve coronary stent restenosis and angina recurrence. It can also regulate blood lipids and inhibit inflammation, which is worthy of further promotion.

关 键 词:瑞舒伐他汀 冠脉支架 血脂 炎性因子 

分 类 号:R541.4[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象